INTERMUNE PHARMACEUTICALS INC
POS AM, EX-27.2, 2000-10-30
PHARMACEUTICAL PREPARATIONS
Previous: INTERMUNE PHARMACEUTICALS INC, POS AM, EX-23.1, 2000-10-30
Next: INTERMUNE PHARMACEUTICALS INC, POS AM, EX-27.3, 2000-10-30



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
 This schedule contains summary financial information extracted from financial
statements for the six month period ending June 30, 2000, and is qualified
in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                   1.00
<CASH>                                         127,740
<SECURITIES>                                         0
<RECEIVABLES>                                    1,729
<ALLOWANCES>                                     (175)
<INVENTORY>                                        357
<CURRENT-ASSETS>                               133,517
<PP&E>                                             721
<DEPRECIATION>                                    (39)
<TOTAL-ASSETS>                                 134,449
<CURRENT-LIABILITIES>                            2,544
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            22
<OTHER-SE>                                     131,883
<TOTAL-LIABILITY-AND-EQUITY>                   134,449
<SALES>                                          3,133
<TOTAL-REVENUES>                                 3,133
<CGS>                                          (3,160)
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                              (15,065)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (134)
<INCOME-PRETAX>                               (12,531)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,531)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,531)
<EPS-BASIC>                                     (3.42)
<EPS-DILUTED>                                   (3.42)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission